New avenues for the optimisation of dendritic cell-based cancer immunotherapies

Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines
12 October 2021
This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo
12 October 2021

New avenues for the optimisation of dendritic cell-based cancer immunotherapies

A recent study from the University of Helsinki reveals that inhibiting certain adhesion receptors on the surface of dendritic cells, the main antigen-presenting cells of the immune system, enhances antitumour responses. 

Comments are closed.